Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy

Sponsor
Shandong University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02169388
Collaborator
(none)
30
1
2
7
4.3

Study Details

Study Description

Brief Summary

Probiotics modulate the gut microflora and immune status in CRC,which can reduce the side effects of chemotherapy such as diarrhea,infection,neutropenia etc.

Condition or Disease Intervention/Treatment Phase
Phase 1

Detailed Description

Chemotherapy destroys the intestinal mucosal barrier, affects intestinal flora, causing bacterial translocation, infection and other complications; Probiotics may restore the intestinal immunity, mucosal barrier, and nutrient absorption.The adverse effects of chemotherapy and the malnutrition status may be relieved via probiotic administration.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Primary Purpose:
Supportive Care
Official Title:
Effects of Gut Microflora on the Immune and Nutritional Status of CRC Patients After Chemotherapy
Study Start Date :
Jun 1, 2014
Anticipated Primary Completion Date :
Oct 1, 2014
Anticipated Study Completion Date :
Jan 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Probiotic

Microbial composition using Probiotic,3 capsules / times, 2 times / day for 4 weeks

Drug: Probiotic
Microbial composition using probiotic
Other Names:
  • containing
  • ( clostridium butyricum)
  • Placebo Comparator: placebo

    Microbiota modulation using placebo,3 capsules / times, 2 times / day for 4 weeks

    Drug: placebo(for probiotic)
    microbiota modulation using placebo

    Outcome Measures

    Primary Outcome Measures

    1. Composition of Microorganisms in stool after probiotic intervention [5 months]

      Primary coordination of fecal samples' 16s rDNA (ribosomal DNA) will be compared between two Groups using Braycurtis distance based Primary coordination analysis (PCoA).

    2. Short-chain fatty acids in feces of patients after chemotherapy [5 months]

      The total concentration of Short-chain fatty acids in the in feces of patients after chemotherapy.

    3. Frequency and severity of Adverse effects during Chemotherapy [5 months]

      Adverse effects includes vomiting, nausea, diarrhea and abdominal pain.

    Secondary Outcome Measures

    1. The observed changes in immune status after chemotherapy [5 month]

      Immune status indexes include percentage of Neutrophils, total lymphocytes, lymphocyte subgroups, plasma immunoglobulin level, CRP (C reactive protein).

    2. The observed changes in nutritional status after chemotherapy [5 months]

      Nutritional status indexes include BMI, percentage of body weight changes, plasma albumin and prealbumin.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients scheduled for chemotherapy after radical resection of colorectal cancer
    Exclusion Criteria:
    • Palliative resection of colorectal cancer

    • Antibiotic,probiotic or prebiotic usage within 1months

    • Other malignancy

    • History of other abdominal surgery

    • Coagulopathy or bleeding disorders

    • Pregnant or breast-feeding(for females)

    • Impaired liver or renal function

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Gastroenterology,Qilu Hospital,Shandong University Jinan Shandong China 250012

    Sponsors and Collaborators

    • Shandong University

    Investigators

    • Principal Investigator: Yanqing Li, MD.PhD, Qilu Hospital,Shandong University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yanqing Li, Vice president of Qilu Hospital, Shandong University
    ClinicalTrials.gov Identifier:
    NCT02169388
    Other Study ID Numbers:
    • 2014SDU-QILU-G03
    First Posted:
    Jun 23, 2014
    Last Update Posted:
    Jun 25, 2014
    Last Verified:
    Jun 1, 2014
    Keywords provided by Yanqing Li, Vice president of Qilu Hospital, Shandong University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 25, 2014